2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth ylpropanoate(CAS: 126544-47-6)
![2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate 2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth
ylpropanoate](https://cnstatic.chemtradehub.com/structs/126/126544-47-6-bc8f.webp)
CAS号
相关产品
其他供应商提供的 2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-meth ylpropanoate
基本信息
分子式
C32H44O7
分子量
540.7 g/mol
Physical Properties
熔点
206-213°C
沸点
665°C at 760 mmHg
化学标识符
SMILES
CC(C)C(=O)OCC(=O)[C@]12O[C@@H](O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@@]31C)C6CCCCC6
InChIKey
LUKZNWIVRBCLON-GXOBDPJESA-N
数据库引用
MDL号
MFCD00866004
常见问题
环索奈德是一种化学物质,其英文名称为2-[(4aR,4bS,6aS,6bS,8R,9aR,10aS,10bS)-8-Cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-methylpropanoate,CAS号为126544-47-6。环索奈德是一种1,4-二氢-2H-3,1-benzoxazin-2-one衍生物,主要用于治疗哮喘和过敏性鼻炎等疾病。
环索奈德主要用于治疗哮喘和过敏性鼻炎等疾病。它具有强大的抗炎作用和免疫调节作用,能够有效缓解哮喘症状和减少鼻炎发作。此外,环索奈德还被用于研究以探索其在其他疾病中的潜在应用。
环索奈德在临床应用中被认为是相对安全的,但使用时仍需注意一些安全事项。使用过程中可能会出现一些副作用,如头痛、鼻塞、喉咙痛、声音嘶哑等。对于某些患者,可能会出现更严重的反应,如过敏反应。因此,在使用时应遵循医生的指导,避免接触眼睛、口腔和其他敏感部位,并注意个人防护措施。
环索奈德应储存在阴凉、干燥、通风良好的地方,避免直接暴露在阳光下。储存温度应控制在室温范围内,避免过高或过低的温度,以防药品变质。储存时应使用密封容器,远离火源和热源。此外,储存过程中应避免与其他有毒或易燃物质接触,以确保安全。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序
联系信息
邮箱
1966662161@qq.com


![N-[(1R)-1-(Dihydroxyboryl)-3-methylbutyl]-Nalpha-(2-pyrazinylcarbonyl)-L-phenylalaninamide](https://cnstatic.chemtradehub.com/structs/179/179324-69-7-701f.webp)
![Methyl {(5S,10S,11S,14S)-11-benzyl-10-hydroxy-15,15-dimethyl-5-(2-methyl-2-propanyl)-3,6,13-trioxo-8-[4-(2-pyridinyl)benzyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl}carbamate sulfate (1:1) (non-preferr
ed name)](https://cnstatic.chemtradehub.com/structs/229/229975-97-7-ce03.webp)
![2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide hydrobromide](https://cnstatic.chemtradehub.com/structs/133/133099-07-7-e564.webp)

![4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole hydrochloride (1:1)](https://cnstatic.chemtradehub.com/structs/145/145108-58-3-a981.webp)
![(5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl}-N-ethyl-5-heptenamide](https://cnstatic.chemtradehub.com/structs/155/155206-00-1-3faa.webp)

![Sodium (3R,5S,6E)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate](https://cnstatic.chemtradehub.com/structs/143/143201-11-0-8b92.webp)